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Introduction
Aging is clearly agreed to be critical in the etiology of metabolic
decline in most human subjects as they near their 65th birthday. A
great many human subjects at 65 years of age demonstrate clear
signs of metabolic and physiological decline, atherosclerosis in
most major arteries, high blood pressure, high serum cholesterol
levels, diverse cardiovascular diseases, and often type 2 diabetes
mellitus, which contribute in major ways to congestive heart
failure by their 75th-85th years. It must be pointed out, here, that
all of these aberrations have been shown (or to be associated
with) both experimentally and clinically, with the presence of
magnesium deficiency (MgD) when they are carefully looked for
[1-10].
Magnesium deficiency and cardiovascular diseases
Disturbances in diet are known to promote lipid deposition and
accelerate the growth and transformation of smooth muscle cells
in the vascular walls and to promote cardiac dysfunction [3, 9-11].
Several epidemiologic studies in North America and Europe
have shown that people consuming Western-type diets are low
in magnesium (Mg) content (i.e., 30-65% of the RDA for Mg
[8-10, 12, 13]; most such diets in the U.S.A. show that 60-80%

of Americans are consuming 185-235 mg/day of Mg [8, 13]. In
1900, in contrast, Americans were consuming 450-550 mg/day
of Mg [5, 8]. Low Mg content of drinking water, found in areas
of soft-water and Mg-poor soil, is associated with high incidences
of atherosclerosis, ischemic heart disease (IHD), coronary
vasospasm, hypertension, and sudden-cardiac death (SCD) [2, 5,
8, 14-18]. Both animal and human studies have shown an inverse
relationship between dietary intake of Mg and atherosclerosis [5,
6, 8, 9, 19-21]. The myocardial level of Mg has consistently been
observed to be lower in subjects dying from IHD and SCD in
soft-water areas than those in hard-water areas [2, 4-6, 8, 9, 19-21].
Mg plays essential roles in more than 500 enzymatic reactions in
the body and is required for all energy-generating reactions and
oxidative phosphorylation [22]. More than 45 years ago, two of
us demonstrated that Mg2+ behaves as a natural calcium channel
blocker in both cardiac and vascular smooth muscle (VSM) cells
[2, 23-26]. We also showed in experimental animals that Mg
behaves as a natural statin in that it can lower blood cholesterol
and triglyceride levels as well as act as a powerful vasodilator
in the microcirculation and cardiac muscle relaxant [4, 6-8, 19,
27-30]. Hypermagnesemic diets have been shown to ameliorate
hypertension and atherogenesis [1-6, 8-10, 19-22, 32-34]. Using
sensitive and newly designed specific Mg2+-ion selective electrodes,
our laboratories demonstrated that patients with hypertension,
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IHD, cardiac failure, strokes, diabetes types 1 and 2, gestational
diabetes, renal-induced vascular changes (associated with elevated
serum cholesterol), preeclampsia, hemorrhage, sickle cell anemia
in children (and adults), and atherosclerosis exhibit significant
reductions in serum/plasma/whole blood levels of ionized, but
not total blood levels of Mg [5, 6, 8, 34-56]. Our group has also
shown that dietary deficiency in rabbits and rats causes vascular
remodeling concomitant with atherogenesis (i.e., arteriolar wall
hypertrophy and alterations in the matrices of the vascular walls)
and hypertension [4-6, 8, 19, 57-59]. These exciting results have
been confirmed, essentially, by other investigators [20, 21, 32,
33]. Some of these results have recently been observed to result
in an acceleration of the aging process [60, 61]. A number of
the pathophysiological and molecular-biochemical alterations
typically noted in tissues and cells in the aging process have been
noted in MgD tissues and cells recently by our group and some
other investigators [4, 6-8, 19, 61-72].
Magnesium deficiency associated with pathophysiological
and biochemical alterations characteristic of aging tissues
and cells: relationship to telomerases, ceramide, NF-kB and
proto-oncogenes
It is well-known that the aging process is associated with
elevations in blood/serum/tissue/cell levels of many of the
same proinflammatory cytokines and chemokines found in
MgD animals, eg., IL-1, IL-2, IL-6, TNF-alpha, among others
[for recent reviews, see [61]]. Reduced levels of telomerases are
known to be associated with elevated levels of several cytokines
(e.g., TNF-alpha) in a number of aged cell types as well as in
serum and cardiovascular tissues and VSM cells of MgD animals
[for recent review, see [61]]; these phenomena being associated
with (and correlated to ionized Mg levels; ceramide generation;
and activation of NF-kB and proto-oncogene pathways) [61, 67,
68, 74-76]. It should be pointed out, here, that normal amounts
of telomerases in all cell types are required to promote efficient
cell cycle kinetics and normal cell growth [77, 78]. MgD is wellknown to promote disturbances in cell cycle kinetics [79-81]
via reactive oxygen and nitrogen species, most likely acting to
downregulate telomerases [61]. Several studies have demonstrated
that MgD, both in situ and in vitro, cause formation of reactive
oxygen (ROS) and nitrogen species (NOS) [5, 6, 8, 61, 63-69].
Interestingly, the increased levels of cellular ROS and NOS were
found to be associated with oxidation of DNA and increased
levels of the tumor suppressor gene, increased levels of p53 and
ceramide, in cardiovascular tissues and cells of MgD animals [61,
67, 68, 74-76].
Magnesium deficiency causes oxidation of DNA and
increased levels of ceramide and p53: possible relation to
cellular mutations and epigenetics
Recently, our laboratories have shown in animals, subjected to
21 days of MgD, that telomerase levels are downregulated and
coupled to fragmentation and oxidation of DNA and increased
levels of the tumor suppressor gene, p53 [61, 74]. We believe such
data supports the idea that MgD could lead to multiple mutations
in the genomes of multiple cell types found in the initiation of
atherogenesis and congestive heart failure. Previous studies from
our group [8, 61-64, 67, 68, 74-76, 82, 83], when viewed in the light
of these findings, would lend additional support to the hypothesis
that mutations and transformations of VSM cells, endothelial cells,
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and cardiac myocytes caused by MgD, fragmentation of DNA,
and oxidation of DNA(all seen in atherogenesis, hypertension,
strokes, and congestive heart failure) may play major roles in the
aging process, thus leading to multiple cardiovascular changes,
including inflammations of the vascular walls, high blood presure
(due to formed elemental changes, release of ceramides, release
of cytokines, excess wall lipid deposition and peroxidation, etc),
cardiac dysfunctions, and eventual cardiac failure.
Several years ago, we suggested that MgD, by itself, probably acts
as a genotoxic agent [74, 76]. As is known, one of ceramide's
major pathophysiological actions is its ability to induce cell
differentiation and transformation [83-87]. Abnormal cell
differentiation, transformation, and growth are pivotal events
of atherogenesis, hypertension, and cardiac failure. Hyperplasia
and cardiovascular hypertrophy are common events in aging,
atherosclerosis, hypertension, and cardiac failure. However,
the precise mechanism(s) regulating alterations in tissue mass
are not completely understood [11, 87]. The tumor suppressor
protein p53, ceramide, and telomerases are now known to play
key roles in cell transformation, apoptotic events, and the aging
process [11, 61, 73, 77, 78]. Both ceramide and p53 can induce
cell cycle arrest (and senescence), induce programmed cell death,
and are associated with oxidation and fragmentation of DNA
(i.e., genotoxic events) [84-86, 88-91]. MgD can produce all of
these alterations in multiple cell types, including cardiac and VSM
cell types [4-6, 8, 59-64, 67, 68, 74-76]. In view of all of these
events noted in MgD animals and cells we would be remiss if
some discussion regarding the potential role of epigenetics to
magnesium deficiency's long-term effects on the aging process
was not pointed out here. All organisms begin as a single cell,
which divides through a process of stem cells creating a mass, via
a series of carefully-designed changes in gene expression, which
is required to form the tissues and cells of the fetal organism.
The process of epigenetics orchestrates which genes have to be
turned-on in each cell type, and then maintains the particular
type of gene expression, or in other words, the particular cell's
molecular identity via how DNA encodes the gene. Anything
that produces modifications in the chromatin structure can affect
a particular gene expression via transcription [92, 93]. Thus, if
MgD-states are, indeed, genotoxic as we have suggested [74,
76], then the chromatin structure of one or more cell types (e.g.,
cardiac, endothelial, or vascular) could be modified and affect one
or more genes and cell phenotype, as is found in atherogenesis.
DNA methylation, histone modification, and microRNA
alterations are known epigenetic pathways. We, thus, believe
that prolonged MgD-states should be categorized as another
epigenetic mechanism. But, how could all of these irreversible
MgD-induced changes be avoided with ease?
Importance of Mg supplemented drinking water and
beverages
Over the past two-plus decades, our laboratories have been
investigating the utility of Mg-supplemented or naturallyoccurring spring waters to avoid the pitfalls of dietary-induced
MgD-states [4-6, 8, 19, 37, 47, 61-68, 74-76]. Our results, so
far, bolster the idea that water intake (e.g., from tap waters, well
waters, bottled waters, beverages using tap/well/spring waters,
or desalinated waters) in humans should contain at least 25-40
mg/liter/day of Mg2+ [61, 68, 74-76]. A number of experiments
done in our labs indicate that most, if not all the cardiovascular
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manifestations observed in experimental animals found to be
MgD, can be avoided by supplementing drinking waters with
appropriate amounts of Mg2+. The latter inclusion in our diets
should go a long-way towards the prevention of cardiovascular
diseases and ameliorate the aging process of bodily tissues and
cells in humans worldwide. Interestingly, on the basis of our work,
the World Health Organization has taken our recommendations
seriously, for the first time [94].

Conclusions
There is a growing awareness that dietary deficiency of magnesium
is becoming a serious problem, particularly in the Western World.
Disturbances in diet are known to promote lipid deposition in
the arterial walls and accelerate growth and transformation
of smooth muscle cells in vascular walls which are linked to
dietary deficiency of magnesium. The myocardial level of Mg
has consistently been observed to be lowered in humans dying
from IHD and sudden-cardiac death in soft-water areas than in
those people living in hard-water areas. Use of specific Mg2+ ionselective electrodes has been useful, clinically, to reveal serious
underlying Mg- deficient states in patients presenting with various
cardiovascular diseases (CVD). Mg deficiency (MgD) is associated
with pathophysiological and biochemical alterations characteristic
of aging cells and tissues which are related to upregulation of
enzymes in the sphingolipid pathway and release of cytokines,
ROS, NOS, activation of NF-kB and proto-oncogenes, resulting in
cellular production of free ceramide, p53, and disturbances in cell
cycle kinetics of vascular smooth muscle and cardiac muscle cells.
The consequences of MgD lead to oxidation and fragmentation
of DNA and inflammation in cells of the cardiovascular system,
phenomena characteristic of atherosclerosis, aging, and CVD. We
suggest that MgD states are genotoxic and, thus, one or more cell
types (e.g., cardiac, endothelial and/or vascular) could be modified
and affect one or more genes and cell phenotype, as is found
in atherogenesis, representing epigenetic cell-induced changes.
Supplementation of drinking waters (including beverages) is
recommended in order to prevent and reduce CVD.
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